2014
DOI: 10.1016/j.acthis.2014.07.009
|View full text |Cite
|
Sign up to set email alerts
|

Nestin expression and glial response in the hippocampus of mice after trimethyltin treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
10
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 60 publications
2
10
0
Order By: Relevance
“…Seizures developed rapidly on day 1 after TMT treatment, peaked on day 2, and then decreased (Fig. 1A, n = 10 mice/group), consistent with data from our previous studies on TMT treatment in mice (Kim et al, 2013; Kim et al, 2014a; Kim et al, 2014b; Lee et al, 2014). Clinical symptoms in the recovery stage (days 4–8 post-injection) were significantly decreased compared to the peak stage (day 2 post-injection; Fig.…”
Section: Resultssupporting
confidence: 90%
See 1 more Smart Citation
“…Seizures developed rapidly on day 1 after TMT treatment, peaked on day 2, and then decreased (Fig. 1A, n = 10 mice/group), consistent with data from our previous studies on TMT treatment in mice (Kim et al, 2013; Kim et al, 2014a; Kim et al, 2014b; Lee et al, 2014). Clinical symptoms in the recovery stage (days 4–8 post-injection) were significantly decreased compared to the peak stage (day 2 post-injection; Fig.…”
Section: Resultssupporting
confidence: 90%
“…Consistently, TMT induces neuronal degeneration, but the lesion subsequently recovers, and it has been shown that newborn neurons replace the damaged ones in the SGZ (Harry et al, 2004; Ogita et al, 2005). After TMT injection, the course of clinical symptoms in mice is consistent with the histopathological changes in the mouse hippocampus (Lee et al, 2014). This study further showed that the TMT-induced injury was most severe on day 2 in the hippocampal DGs, but the lesions were alleviated by 4 days post-injection; the severity of cell loss and the number of TUNEL-positive cells remarkably decreased in the DG at 4 days post-injection, consistent with the clinical symptoms.…”
Section: Discussionmentioning
confidence: 56%
“…In many neurological diseases, astrocytes become activated. Astrocyte activation and reactive gliosis leads to an upregulation of IF proteins . Astrocytes express the IF proteins GFAP, vimentin and nestin, which are linked to phenomena such as cell motility, protein phosphorylation, wound healing, protection of neurons in the ischaemic brain and regenerative responses in various kinds of CNS injury .…”
Section: Introductionmentioning
confidence: 99%
“…TMT is a well‐known neurotoxin that induces neurodegeneration in the hippocampus (Lattanzi et al, 2013; Lee et al, 2014). The TMT neurodegenerative mechanism included impairments in GABAR functions and disturbances in GABAergic inhibitory neurotransmission (Kruger et al, 2005; Nishimura et al, 2001).…”
Section: Discussionmentioning
confidence: 99%
“…Trimethyltin (TMT) is an organo‐tin compound that induces neurotoxicity in the mammalian limbic system, particularly the hippocampus, in experimental animals (Lattanzi et al, 2013; Lee et al, 2014). Exposure to TMT induces neurodegeneration and causes extensive neuronal loss, cognitive impairment, and behavioral dysfunction, including aggressiveness, epileptic seizure, and ataxia (Bertram and Cornett, 1994; Besser et al, 1987; Ishida et al, 1997; Kim et al, 2014a).…”
Section: Introductionmentioning
confidence: 99%